Contact us

Support


Bionorica SE

Michael Popp, Chief Executive Officer and Company Owner, has told during the press-conference today that Bionorica pharmaceutical company (Germany) intends to commission the plant in Maslovskiy industrial park near Voronezh in 2021. The investor plans to finish construction of manufacturing lines by 2019, the quality analysis and product registration in Russia will take two more years.

10 July 2017
RBC

The construction of the Bionorica pharmaceutical plant will start in the Maslovsky industrial park near Voronezh in 2017. So Chairman of the Management Board of Bionorica SE Michael Popp told today at the meeting with the Governor of the Voronezh Region Aleksey Gordeev. The estimated capacity of the plant is 120 mln blisters per year. The launch of the enterprise with 116 jobs is planned for 2018. The investment volume is about 2.5 bln. rubles. The capacity is planned to increase to 200 mln blisters by 2020, the number of jobs increasing to 189.

19 October 2016
TASS

On 1 June Governor Alexei Gordeyev met Professor Michael Popp, chairman of Bionorica SE. They discussed the plans of the pharmaceutical companies Bionorica SE and Aenova GmbH to build a pharmaceutical enterprise in the region. The site of almost 12 hectares that this will need has been chosen in the Maslovsky industrial park. The total investment is 30 million euros, the regional administration’s press office reported.

The project includes building a factory to produce medicinal products using the method of extraction from natural raw materials (medicinal herbs). The companies currently grow the raw materials for their products on their own sites in Majorca (Spain), but they are looking at the possibility of growing part of their medicinal herbs in Voronezh Region. The Pavlovskaya Niva company has contracted with the company to sow trial fields with four medicinal crops and has already obtained its first good cultivation results.

According to Michael Popp, one of the next steps will be to sign a contract to lease a plot of land, which will take place in the near future. Bionorica SE plans to start building the factory in 2016.

01 June 2015
http://www.pharmvestnik.ru
Investor

Investor profile

Bionorica SE

Germany

Company's website: www.bionorica.com

T: +49 (09181) 231 - 90

Private company

E-mail: info@bionorica.de

Contact: Prof. Michael A. Popp, CEO

Bionorica SE is one of the world’s biggest producers of phytopharmaceutical products.

Subscribe to Newsletters

Email: